Owen Wallace

Chief Scientific Officer at Monte Rosa Therapeutics

Dr. Wallace joined Monte Rosa from Fulcrum Therapeutics, where he served as Chief Scientific Officer since 2017. Prior, he was the Head of Global Discovery Chemistry at Novartis Institutes of BioMedical Research. Earlier, Dr. Wallace spent ten years with Eli Lilly and Company in various positions, including global leadership roles as Senior Director of Discovery Chemistry Research and Site Scientific Leader at the Lilly Research Center in Surrey, U.K. Dr. Wallace began his career at Bristol Myers-Squibb as a Research Investigator. He holds a Ph.D. from Yale University.

Links

Previous companies

Bristol-Myers Squibb logo
Fulcrum Therapeutics logo
Novartis logo

Timeline

  • Chief Scientific Officer

    February, 2021 - present

View in org chart